CareDx
CareDx
Explore linked clinical trials.8 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Molecular Assessment and Profiling of Liver Transplant Recipients | Biomarkers; Liver Transplantation | Active, not recruiting | Not stated | 2026-09-03 | NCT04793360 | |
| Assessment of Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT) Using AlloHeme Test | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, acute myeloid leukemia, bone marrow disorder, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, myelodysplastic syndrome, myeloid leukemia, neoplasm | Active, not recruiting | Not stated | 2026-09-03 | NCT04635384 | |
| Surveillance HeartCare® Outcomes Registry | Heart Transplant Rejection | Active, not recruiting | Not stated | 2026-09-03 | NCT03695601 | |
| Prospective Reduction Of Transplant Complications Through Enhanced Preservation Therapy to Prevent Primary Graft Dysfunction | Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Primary Graft Dysfunction, cardiovascular disorder, ischemia reperfusion injury, vascular disorder | Recruiting | Not applicable | 2026-07-13 | NCT07230886 | |
| AlloSure Lung Assessment and Metagenomics Outcomes Study | Lung Transplant Failure and Rejection; Lung Transplant Infection; Lung Transplant; Complications | Active, not recruiting | Not stated | 2026-06-25 | NCT05050955 | |
| Forecasting Relapse Outcomes With AlloHeme-based Risk Detection in Post-Allo-HCT AML/MDS Patients (FORWARD) | Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, acute myeloid leukemia, anemia, bone marrow disorder, chronic myelomonocytic leukemia, hematologic disorder, leukemia, myelodysplastic syndrome, myelodysplastic syndrome with excess blasts, myelodysplastic syndrome with single lineage dysplasia, myeloid leukemia, neoplasm | Not yet recruiting | Not stated | 2026-05-26 | NCT07607327 | |
| Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Phase 4 | 2026-04-03 | NCT05060991 | |
| HeartCare Immuno-optimization in Cardiac Allografts (MOSAIC) | Allograft; Heart Transplant; Immunosuppression | Not yet recruiting | Not applicable | 2024-10-23 | NCT05459181 |